Violence / Aggression
Danielle Shayani, M.S. (she/her/hers)
Doctoral Student
University of Delaware
Newark, DE, United States
David DiLillo, Ph.D. (he/him/his)
University of Nebraska-Lincoln
Lincoln, NE, United States
Danielle Shayani, M.S. (she/her/hers)
Doctoral Student
University of Delaware
Newark, DE, United States
Dawn Johnson, Ph.D. (she/her/hers)
University of Akron
Akron, OH, United States
Casey Taft, Ph.D.
National Center for PTSD
Boston, MA, United States
Intimate partner violence (IPV), which includes physical, psychological, and sexual violence, is a public health crisis with far-reaching consequences that affect the lives of those who experience IPV, as well as those who use it. Bridging the gap between research and accessible, affirming, evidence-based interventions is essential to reducing IPV and improving well-being among those affected. Research has focused on applying and developing evidence-based interventions to minimize IPV and reduce symptoms associated with the aftermath. However, there is substantial room for improvement, given the considerable dropout rates, relapse and recidivism rates, and mixed effect sizes across existing treatments for those who use IPV and those who are affected by it. Furthermore, to increase the reach and impact of these treatments, it is critical to develop scalable, accessible, and culturally responsive interventions that address the diverse needs of individuals and families affected by IPV.
The research in this symposium will highlight innovations in treatment from multiple perspectives including men who use IPV, survivors, and the family system. Additionally, we will discuss potential strategies to enhance implementation, aiming to improve access to evidence-based treatments for IPV. First, [masked for review] will present an overview of Fathers for Change (F4C), a newly developed cognitive-behavioral treatment for fathers who use IPV. F4C includes individual sessions focused on emotion regulation and reflective functioning skills, followed by co-parent and family sessions. She will also present predictors of IPV and emotion regulation outcomes based on coding sessions from a randomized clinical trial comparing F4C to the current standard of care, Batterer Intervention Program (BIP). Second, [masked for review] will present preliminary findings comparing a novel online intervention for perinatal women experiencing IPV to a control condition matched on attention, time, and information. Third, [masked for review] will provide a theoretical overview of the Strength at Home program for veterans, discuss implementation progress, and provide a summary of empirical data to date. Finally, our discussant, [masked for review], will describe the causes and consequences of IPV and how this can further inform IPV treatment development.
Attendees will learn about the latest advancements in IPV treatment and learn how interventions can be adapted to improve engagement and accessibility. Furthermore, attendees will develop a deeper understanding of how innovations in IPV treatment—including digital interventions and process-based adaptations—can extend access to underserved populations, improve treatment retention, and ultimately reduce the burden of IPV in various communities.
Speaker: Danielle R. Shayani, M.S. (she/her/hers) – University of Delaware
Co-author: Carla Stover, Ph.D. (she/her/hers) – Yale University
Co-author: Damion Grasso, Ph.D. – UCONN Health Center
Co-author: Adele M. Hayes, Ph.D. (she/her/hers) – University of Delaware
Speaker: Dawn M. Johnson, Ph.D. (she/her/hers) – University of Akron
Co-author: Golfo Wernette, Ph.D. – University of Michigan, Department of Family Medicine
Co-author: Ananda Sen, Ph.D. – Department of Family Medicine, University of Michigan
Co-author: Kristina Countryman, MPH – Department of Family Medicine, University of Michigan
Co-author: Caron Zlotnick, Ph.D. – Women & Infants Hospital
Speaker: Casey Taft, Ph.D. – National Center for PTSD